Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Feb;68(2):796-800.
doi: 10.1128/IAI.68.2.796-800.2000.

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

D E Briles  1 , E Ades, J C Paton, J S Sampson, G M Carlone, R C Huebner, A Virolainen, E Swiatlo, S K Hollingshead
Affiliations

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

D E Briles et al. Infect Immun. 2000 Feb.

Abstract

Acquisition of pneumococci is generally from carriers rather than from infected individuals. Therefore, to induce herd immunity against Streptococcus pneumoniae it will be necessary to elicit protection against carriage. Capsular polysaccharide-protein conjugates, PspA, and PsaA are known to elicit some protection against nasopharyngeal carriage of pneumococci but do not always completely eliminate carriage. In this study, we observed that PsaA elicited better protection than did PspA against carriage. Pneumolysin elicited no protection against carriage. Immunization with a mixture of PsaA and PspA elicited the best protection against carriage. These results indicate that PspA and PsaA may be useful for the elicitation of herd immunity in humans. As PspA and pneumolysin are known to elicit immunity to bacteremia and pneumonia, their inclusion in a mucosal vaccine may enable such a vaccine to prevent invasive disease as well as carriage.

PubMed Disclaimer

References

    1. Abeyta M. Pneumococcal surface protein A and capsular polysaccharides in virulence of Streptococcus pneumoniae. Thesis. Birmingham.: University of Alabama at Birmingham; 1999.
    1. Alexander J E, Berry A M, Paton J C, Rubins J B, Andrew P W, Mitchell T J. Amino acid changes affecting the activity of pneumolysin alter the behavior of pneumococci in pneumonia. Microb Pathog. 1998;24:167–174. - PubMed
    1. Alexander J E, Lock R A, Peeters C C A M, Poolman J T, Andrew P W, Mitchell T J, Hansman D, Paton J C. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun. 1994;62:5683–5688. - PMC - PubMed
    1. Benton K A, Paton J C, Briles D B. Differences in virulence of mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect Immun. 1997;65:1237–1244. - PMC - PubMed
    1. Benton K A, Paton J C, Briles D E. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model. Microb Pathog. 1997;23:201–209. - PubMed

Publication types